Long Non-Coding RNA in the Pathogenesis of Cancers

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Cancer is a leading global cause of death with increasing incidence and mortality.
• Current diagnostic methods often fail to detect cancer early, and existing treatments have limited efficacy.
• There is a critical need for novel biomarkers and therapeutic targets for improved cancer diagnosis, treatment, and prognosis.

Purpose of the Study:

• To review the latest findings on the roles and mechanisms of long non-coding RNAs (lncRNAs) in cancer pathogenesis.
• To highlight the potential of lncRNAs as biomarkers and therapeutic targets for various malignancies.

Main Methods:

• Literature review of recent studies on lncRNAs in cancer.
• Analysis of lncRNA dysregulation in tumor growth and metastasis.
• Focus on specific cancers: lung, breast, liver, colorectal, hematological malignancies, and neuroblastoma.

Main Results:

• Long non-coding RNAs (lncRNAs) are involved in the pathogenesis of numerous diseases, including cancer.
• Dysregulated lncRNA profiles are implicated in tumor growth and metastasis.
• Specific lncRNAs demonstrate potential as sensitive and effective biomarkers and therapeutic targets.

Conclusions:

• lncRNAs play significant roles in the development and progression of various cancers.
• lncRNAs represent a promising new avenue for early cancer diagnosis, treatment, and prognosis.
• Further research into lncRNA mechanisms can lead to more effective cancer therapies.